Can a Newborn’s Genes Predict Sepsis? New Study Offers Promise

Neonatal sepsis, a potentially fatal bacterial infection in infants under 28 days old, poses a serious threat to newborn health globally. Recognizing the devastating consequences of delayed diagnosis, researchers have made a significant breakthrough: identifying gene expression markers that can predict sepsis at birth.

The Urgency of Early Detection

Sepsis, a life-threatening response to infection, manifests differently across age groups. In neonates, it can lead to organ failure and death. Sadly, the non-specific symptoms often delay diagnosis, making timely treatment critical. Currently, methods like blood cultures are insufficient for early and accurate identification.

New Hope from Gene Expression Markers

A recent study published in eBioMedicine offers a ray of hope. Researchers have identified specific gene expression profiles that can predict neonatal sepsis before clinical symptoms appear. This breakthrough could revolutionize early detection and treatment.

Analyzing Gene Expression Patterns

The study, involving 720 healthy full-term neonates in The Gambia, analyzed blood samples collected at birth and subsequent days.
Comparing healthy neonates with those who developed sepsis, researchers found distinct gene expression changes even before clinical signs emerged.

Key findings included:

• **Early-onset sepsis (EOS)** exhibited 1,067 differentially expressed genes compared to late-onset sepsis (LOS), localized infections, and healthy controls
• **Heat shock proteins**, such as HSPH1 and DNAJB1, were significantly upregulated in EOS cases and emerged as major predictors.
• A 4-gene signature (HSPH1, PRIM1, BORA, and NCAPG2) demonstrated exceptional predictive ability for EOS with an AUC of 0.94, sensitivity of 0.93, and specificity of 0.92.

Pathway Analysis Uncovers Immune System Disruptions

Pathway analysis revealed disruptions in cellular processes like heat shock response and cell cycle pathways, highlighting the early impact of sepsis on the newborn’s immune system.

Potential for Improved Diagnostics

These findings pave the way for improved diagnostic tools for neonatal sepsis, particularly in low- and middle-income countries where access to quality healthcare remains a challenge. Early identification and treatment could save countless lives.

Taking Action: Investing in Newborn Health

This study highlights the crucial need for continued research and investment in newborn health. By supporting initiatives that focus on early sepsis detection and treatment, we can make a real difference in saving the lives of vulnerable infants worldwide.